Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Seattle Children’s Research Institute, the research division of Seattle Children’s Hospital and a leader in pediatric research, and Genezen, a gene and cell therapy contract development and manufacturing organization, have unveiled a strategic ...
read more
Monday, December 06, 2021
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has officially opened its new process development and ...
read more
Wednesday, October 12, 2022
Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, has completed another expansion phase at its viral vector process development and cGMP vector ...
read more
Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has broken ground on a new multiphase master...
read more
Genezen Laboratories Inc. a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has further strengthened its senior leadership team with the appointment of Brok Weichbrodt as Vice President of Operations.
read more
Tuesday, January 25, 2022
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing services, has appointed Laura Jacanin as Senior Director of ...
read more
Thursday, December 01, 2022
Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, continues to scale and expand its commercial operations with the appointment of Jeff Whitmore ...
read more
Thursday, November 13, 2025
Genezen and Humane announced a partnership for process transfer and cGMP manufacturing of HGI627, a novel therapy targeting pediatric liver cancer (hepatoblastoma).
read more
Thursday, September 26, 2019
GENEWIZ announced the opening of its European headquarters for its genomics business in Leipzig, Germany.
read more
CUNY (City University of New York) and Genestack Ltd are pleased to announce their collaboration aimed at streamlining data curation for the BioConductor program.
read more
GBG and its CRO arm GD3 has acquired the Berkeley-based CRO Integrated Analytical Solutions.
read more
Genesis Drug Discovery & Development has announced the appointment of Olesia Buiakova, M.D., Ph.D., the Chief Scientific Officer of Invivotek as its new Chief Scientific Officer.
read more
Thursday, September 30, 2021
Genesis Drug Discovery & Development (GD3), the contract research organization (CRO) arm of Genesis Biotechnology Group® (GBG), has announced the appointment of Anthony Rohr, current Chief Executive Officer of PharmOptima, as its new Chief Operating ...
read more
Wednesday, November 07, 2018
Genesis Biotechnology Group and GD3 has entered into a partnership with Yale University.
read more
Wednesday, December 09, 2020
GBG and its CRO arm GD3 has expanded its relationship with Yale University to continue to offer GD3's integrated portfolio of preclinical services to the awardees of the Blavatnik Fund for Innovation.
read more